123 related articles for article (PubMed ID: 7495359)
1. The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers.
Peters W; Robinson BL; Mittelholzer ML; Crevoisier C; Stürchler D
Ann Trop Med Parasitol; 1995 Oct; 89(5):465-8. PubMed ID: 7495359
[TBL] [Abstract][Full Text] [Related]
2. The chemotherapy of rodent malaria. LIV. Combinations of 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites.
Fleck SL; Robinson BL; Peters W
Ann Trop Med Parasitol; 1997 Jan; 91(1):33-9. PubMed ID: 9093427
[TBL] [Abstract][Full Text] [Related]
3. The chemotherapy of rodent malaria. XLVI. Reversal of mefloquine resistance in rodent Plasmodium.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1991 Feb; 85(1):5-10. PubMed ID: 1888220
[TBL] [Abstract][Full Text] [Related]
4. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605.
Peters W; Robinson BL; Milhous WK
Ann Trop Med Parasitol; 1993 Dec; 87(6):547-52. PubMed ID: 8122915
[TBL] [Abstract][Full Text] [Related]
5. The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
Peters W; Stewart LB; Robinson BL
Ann Trop Med Parasitol; 2003 Apr; 97(3):221-36. PubMed ID: 12803854
[TBL] [Abstract][Full Text] [Related]
6. The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo.
Peters W; Robinson BL; Rossier JC; Misra D; Jefford CW; Rossiter JC
Ann Trop Med Parasitol; 1993 Feb; 87(1):9-16. PubMed ID: 8346994
[TBL] [Abstract][Full Text] [Related]
7. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
Awasthi A; Dutta GP; Bhakuni V; Tripathi R
Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
[TBL] [Abstract][Full Text] [Related]
8. The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1992 Oct; 86(5):455-65. PubMed ID: 1288426
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1999 Jun; 93(4):325-9. PubMed ID: 10656034
[TBL] [Abstract][Full Text] [Related]
10. Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.
Tripathi R; Pandey SK; Rizvi A
Parasitology; 2011 Aug; 138(9):1069-76. PubMed ID: 21756423
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice.
Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP
Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384
[TBL] [Abstract][Full Text] [Related]
12. The chemotherapy of rodent malaria. LIX. Drug combinations to impede the selection of drug resistance, Part 3: Observations on cyproheptadine, an antihistaminic agent, with chloroquine.
Peters W; Robinson BL; Stewart LB; Butcher GA
Ann Trop Med Parasitol; 2000 Oct; 94(7):689-97. PubMed ID: 11144810
[TBL] [Abstract][Full Text] [Related]
13. Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model.
Bhardwaj J; Siddiqui AJ; Goyal M; Prakash K; Soni A; Puri SK
Acta Trop; 2016 Jun; 158():130-138. PubMed ID: 26925772
[TBL] [Abstract][Full Text] [Related]
14. Haem polymerase as a novel target of antimalarial action of cyproheptadine.
Agrawal R; Tripathi R; Tekwani BL; Jain SK; Dutta GP; Shukla OP
Biochem Pharmacol; 2002 Nov; 64(9):1399-406. PubMed ID: 12392821
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium yoelii nigeriensis: biological mechanisms of resistance to chloroquine.
Beauté-Lafitte A; Altemayer-Caillard V; Chabaud AG; Landau I
Parasite; 1994 Sep; 1(3):227-33. PubMed ID: 9140489
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737.
Ridley RG; Matile H; Jaquet C; Dorn A; Hofheinz W; Leupin W; Masciadri R; Theil FP; Richter WF; Girometta MA; Guenzi A; Urwyler H; Gocke E; Potthast JM; Csato M; Thomas A; Peters W
Antimicrob Agents Chemother; 1997 Mar; 41(3):677-86. PubMed ID: 9056013
[TBL] [Abstract][Full Text] [Related]
17. The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of drug resistance, Part 1: Which model is appropriate?
Peters W
Ann Trop Med Parasitol; 1999 Sep; 93(6):569-87. PubMed ID: 10707103
[TBL] [Abstract][Full Text] [Related]
18. The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents.
Peters W; Ekong R; Robinson BL; Warhurst DC; Pan XQ
Ann Trop Med Parasitol; 1990 Dec; 84(6):541-51. PubMed ID: 1981663
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial herbs against chloroquine-resistant P. yoelii nigeriensis in mice.
Kimbi HK; Fagbenro-Beyioku AF; Oyibo WA
Indian J Malariol; 1998 Mar; 35(1):35-8. PubMed ID: 10319560
[No Abstract] [Full Text] [Related]
20. Comparative evaluation of blood schizontocidal activity of quinine and quinidine against drug resistant rodent malaria.
Kazim M; Puri SK; Dutta GP
J Commun Dis; 1991 Dec; 23(4):254-6. PubMed ID: 1842807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
